Serum copper is decreased in premature newborns and increased in newborns with hemolytic jaundice

Clinical Chemistry

Volumn 50, Issue 7, 2004, Pages 1253-1256

  Schulpis, Kleopatra H ^a   Karakonstantakis, Theodoras ^a   Gavrili, Stavroula ^b   Costalos, Christos ^b   Roma, Eleftheria ^c   Papassotiriou, Ioannis ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CERULOPLASMIN; COPPER; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; LACTATE DEHYDROGENASE; LIVER ENZYME;

ANALYSIS OF VARIANCE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BILIRUBIN BLOOD LEVEL; CERULOPLASMIN BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN JAUNDICE; PREMATURITY;

ANEMIA, HEMOLYTIC; COPPER; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 3042560410     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.031773     Document Type: Article

References (27)

1. Ostermeier C, Iwata S, Michel H. Cytochrome c oxidase. Curr Opin Struct Biol 1996;6:460-6.
2. Sullivan JL, Ochs HD. Copper deficiency and the immune system. Lancet 1978;2:686.
3. Vyas D, Chandra RK. Thymic factor activity, lymphocyte stimulation response and antibody producing cells in copper deficiency. Nutr Res 1983;3:343-50.
4. Araya M, Koletzko B, Uauy R. Copper deficiency and excess in infancy: developing a research agenda. J Pediatr Gastroenterol Nutr 2003;37:422-9.
5. Widdowson E. Trace elements in fetal and early postnatal development. Proc Nutr Soc 1974;33:275-84.
6. Al-Rashid RA, Sprangler J. Neonatal copper deficiency. N Engl J Med 1971;285:841-3.
7. Ashkenazi AS, Levin S, Djaldetti M, Fisher E, Benvestini D. The syndrome of neonatal copper deficiency. Pediatrics 1973;52:523-33.
8. William DM. Copper deficiency in humans. Semin Hematol 1983;20:118-28.
9. Cizewski-Culuta V, Gitlin JD. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, eds. Metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill, 2000:3105-28.
10. Hannam S, McDonnell M, Rennie IM. Investigation of prolonged neonatal jaundice. Acta Pediatr 2000;89:694-7.
11. Maisel JM. Jaundice in neonatology. In: Avery GB, Fletcher MA, McDonald MG, eds. Pathophysiology and management of the newborn, 4th ed. Philadelphia: JB Lippincott, 1994:630-60.
12. Henry RJ, Chiamoris N, Jacobs SL, Seaglove M. Determination of ceruloplasmin oxidase activity in serum. Proc Soc Exp Med Biol 1960;104:620-4.
13. Terres-Martos C, Navarro-Alarcon M, Martin-Lagos F, Lopez-Carcia de la Serrana H, Lopez Martinez MC. Determination of Cu levels in serum of healthy subjects by atomic absorption spectrometry. Sci Total Environ 1997;198:97-103.
14. Bremer J. Manifestations of copper excess. Am J Clin Nutr 1998;67(Suppl):1069-73.
15. Fuentealba C, Aburto EM. Animal models of copper-associated liver disease. Comp Hepatol 2003;2:1-12.
16. Valaes T, Karaklis A, Stavrakakis D, Bavela-Stavrakakis K, Perakis A, Doxiadis SP. Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency. Pediatr Res 1969;3:448-58.
17. Kaplan M, Beutler E, Vreman HJ, Hammerman C, Levy-Lahad E, Renbau P, et al. Neonatal hyperbilirubinemia in G6PD deficient heterozygotes. Pediatrics 1999;104:68-74.
18. Rossipal E, Krachler M, Li F, Micetic-Turk D. Investigation of the transport of trace elements across barriers in humans: studies of placental and mammary transfer. Acta Paediatr 2000;89:1190-5.
19. Chen BH, Tsai JL, Tsai LY, Chao MC. Comparison of serum copper, magnesium, zinc and calcium levels between G6PD deficient and normal Chinese adults. Kaohsiung J Med Sci 1999;15:646-50.
20. Schilsky ML, Scheinberg IH, Sternlieb I. Liver transplantation for Wilson disease. Indications and outcome. Hepatology 1994;19:583-7.
21. Strand S, Hofmann WS, Grambihler A, Hug H, Volkmann M, Otto G, et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD 95 (Apo-l/Fas) mediated apoptosis. Nat Med 1998;4:588-93.
22. Suzuki KT, Shiobara Y, Tachibana A, Ogra Y, Matsumoto K. Copper increases in both plasma and red cells at the onset of acute hepatitis. Res Commun Mol Pathol Pharmacol 1999;103:189-94.
23. Sokol RJ. Antioxidant defenses in metal induced liver damage. Semin Liver Dis 1996;16:39-46.
24. Fridovich J. Superoxide anion radical superoxide dismutases and related matters. J Biol Chem 1997;272:515-7.
25. Sokol RJ, McKim JM, Devereau MW. α-Tocopherol ameliorates oxidant injury of isolated copper overloaded rat hepatocytes. Am J Clin Nutr 1998; 67(Suppl):1012-6.
26. Fridovich J. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995;64:97-112.
27. Van Wassenaer-van Hall HN. Neuroimaging in Wilson's disease. Metab Brain Dis 1996;12:1-19.